Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders

The National Institute on Drug Abuse (NIDA) is soliciting information from qualified organizations to develop and manufacture pharmaceutical dosage forms for the treatment of substance use disorders. The contractor will be responsible for pre-formulation studies, developing and manufacturing dosage forms, quality control tests, stability studies, and distribution of pharmaceutical drug products. The contractor must comply with FDA regulations and have adequate facilities for storage and handling of controlled substances. Some key requirements include: • Pre-formulation studies on bulk drug substances • Development and manufacture of dosage forms • Quality control tests and stability studies • Distribution of pharmaceutical drug products • Compliance with FDA regulations • Adequate facilities for storage and handling of controlled substances